News Image

Tempest Reports Third Quarter 2024 Financial Results and Provides Business Update

Provided By GlobeNewswire

Last update: Nov 12, 2024

BRISBANE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer, today reported financial results for the quarter ended September 30, 2024, and provided a corporate update.

Read more at globenewswire.com

TEMPEST THERAPEUTICS INC

NASDAQ:TPST (7/25/2025, 8:00:01 PM)

After market: 7.8998 +0.14 (+1.8%)

7.76

+1.33 (+20.59%)



Find more stocks in the Stock Screener

Follow ChartMill for more